Studio RIFRA: il rischio fratturativo in Italia

L'osteoporosi \ue8 un disordine scheletrico cronico-evolutivo, caratferizzato dalla perdita dell'equilibrio del metabolismo osseo con conseguente degenerazione quantitativa e qualitativa che compromette la resistenza dell'osso e predispone ad un aumentato rischio di fratture. Colpisce soprattutto il sesso femminile,conunaprevalenza del33%nelrange tra60eT0aacheaumentaconl'avanzaredell'et\ue0. Pu\uf2 rimanere clinicamente silente e successivamente manifestarsi con fratture (vertebrali 100.000 casi/anno, di polso 85.000 casi/anno e femorali 80.000 casi/anno). Le fratture da fragilit\ue0 comportano gravi conse gse\ueeze, sia a livello clinico individuale che sociale ed economico; rappresenrano pertanto una fonte di disabilit\ue0 complessa, che in quanto tale necessita di una presa in carico globale. Lo studio RIFRA nasce da un'idea del GISMO per rispondere alla necessit\ue0 primaria di quantificare il reale rischio fratturativo in Italia attraverso una specifica scheda e di valutare l'influenza delle comorbilit\ue0 e delle terapie corelate al rischio di frattura. L'obiettivo secondario analizzare \a percentuale di pazienti sottoposti a trattamento farmacologico in relazione ai valori densitometrici e alle pregresse fratture, nonch\ue9 valutare la prevalenza di fratture da fragilit\ue0 nella popol azione in studio

Litchi chinensis as a Functional Food and a Source of Antitumor Compounds: An Overview and a Description of Biochemical Pathways

Litchi is a tasty fruit that is commercially grown for food consumption and nutritional benefits in various parts of the world. Due to its biological activities, the fruit is becoming increasingly known and deserves attention not only for its edible part, the pulp, but also for its peel and seed that contain beneficial substances with antioxidant, cancer preventive, antimicrobial, and anti-inflammatory functions. Although literature demonstrates the biological activity of Litchi components in reducing tumor cell viability in in vitro or in vivo models, data about the biochemical mechanisms responsible for these effects are quite fragmentary. This review specifically describes, in a comprehensive analysis, the antitumor properties of the different parts of Litchi and highlights the main biochemical mechanisms involved

SAHA/TRAIL combination induces detachment and anoikis of MDA-MB231 and MCF-7 breast cancer cells

SAHA, an inhibitor of histone deacetylase activity, has been shown to sensitize tumor cells to apoptosis induced by TRAIL, a member of TNF-family. In this paper we investigated the effect of SAHA/TRAIL combination in two breast cancer cell lines, the ERa positive MCF-7 and the ERa negative MDA-MB231. Treatment of MDA-MB231 and MCF-7 cells with SAHA in combination with TRAIL caused detachment of cells followed by anoikis, a form of apoptosis which occurs after cell detachment, while treatment with SAHA or TRAIL alone did not produce these effects. The effects were more evident in MDA-MB231 cells, which were chosen for ascertaining the mechanism of SAHA/TRAIL action. Our results show that SAHA decreased the level of c-FLIP, thus favouring the interaction of TRAIL with the specific death receptors DR4 and DR5 and the consequent activation of caspase-8. These effects increased when the cells were treated with SAHA/TRAIL combination. Because z-IEDT-fmk, an inhibitor of caspase-8, prevented both the cleavage of the focal adhesion-kinase FAK and cell detachment, we suggest that activation of caspase- 8 can be responsible for both the decrement of FAK and the consequent cell detachment. In addition, treatment with SAHA/TRAIL combination caused dissipation of DJm, activation of caspase-3 and decrement of both phospho-EGFR and phospho-ERK1/2, a kinase which is involved in the phosphorylation of BimEL. Therefore, co-treatment also induced decrement of phospho-BimEL and a concomitant increase in the dephosphorylated form of BimEL, which plays an important role in the induction of anoikis. Our findings suggest the potential application of SAHA in combination with TRAIL in clinical trials for breast cancer

Multifaceted Health Benefits of Mangifera indica L. (Mango): The Inestimable Value of Orchards Recently Planted in Sicilian Rural Areas

Historically, Mangifera indica L. cultivations have been widely planted in tropical areas of India, Africa, Asia, and Central America. However, at least 20 years ago its spreading allowed the development of some cultivars in Sicily, an island to the south of Italy, where the favourable subtropical climate and adapted soils represent the perfect field to create new sources of production for the Sicilian agricultural supply chain. Currently, cultivations of Kensington Pride, Keitt, Glenn, Maya, and Tommy Atkins varieties are active in Sicily and their products meet the requirements of local and European markets. Mango plants produce fleshy stone fruits rich in phytochemicals with an undisputed nutritional value for its high content of polyphenolics and vitamins. This review provides an overview of the antioxidant, anti-inflammatory, and anticancer properties of mango, a fruit that should be included in everyone\u2019s diet for its multifaceted biochemical actions and health-enhancing properties

Optimized modeling and design of a pcm-enhanced h2 storage

Thermal and mechanical energy storage is pivotal for the effective exploitation of renewable energy sources, thus fostering the transition to a sustainable economy. Hydrogen-based systems are among the most promising solutions for electrical energy storage. However, several technical and economic barriers (e.g., high costs, low energy and power density, advanced material requirements) still hinder the diffusion of such solutions. Similarly, the realization of latent heat storages through phase change materials is particularly attractive because it provides high energy density in addition to allowing for the storage of the heat of fusion at a (nearly) constant temperature. In this paper, we posit the challenge to couple a metal hydride H-2 canister with a latent heat storage, in order to improve the overall power density and realize a passive control of the system temperature. A highly flexible numerical solver based on a hybrid Lattice Boltzmann Phase-Field (LB-PF) algorithm is developed to assist the design of the hybrid PCM-MH tank by studying the melting and solidification processes of paraffin-like materials. The present approach is used to model the storage of the heat released by the hydride during the H-2 loading process in a phase change material (PCM). The results in terms of Nusselt numbers are used to design an enhanced metal-hydride storage for H-2-based energy systems, relevant for a reliable and cost-effective "Hydrogen Economy". The application of the developed numerical model to the case study demonstrates the feasibility of the posited design. Specifically, the phase change material application significantly increases the heat flux at the metal hydride surface, thus improving the overall system power density

Induction of apoptosis in human retinoblastoma cells by topoisomerase inhibitors

PURPOSE:To examine the apoptotic effect induced in human retinoblastoma Y79 cells by camptothecin, etoposide, and amsacrine, to examine the effect of these drugs on the expression of many apoptosis-related modulators, and to test the antiapoptotic effect exerted by insulin-like growth factor-I (IGF-I). METHODS:Morphologic features of apoptosis were demonstrated using acridine orange- ethidium bromide staining and electron microscopy. DNA fragmentation was determined by means of an in situ cell detection procedure (TdT-dUTP terminal nick-end labeling [TUNEL]) or by electrophoresis on agarose gels and was quantified by enzyme-linked immunosorbent assay. The expression of apoptosis-related modulators was studied by western blot analysis. The processing of latent p53 was examined by means of pulse- chase analysis. RESULTS:Camptothecin, etoposide, and amsacrine induced apoptosis in Y79 cells in a dose-dependent manner; camptothecin was the most efficacious compound. The effect, which was dependent on macromolecular synthesis, appeared after a lag of 8 hours and increased for as long as 24 hours. It was lower in cells treated with IGF-I, a potent mitogenic factor. Camptothecin and etoposide increased the p53 level after 4 hours of treatment, before the onset of apoptosis. This effect seemed to be a consequence of the conversion of latent p53 to one that is transcriptionally active. The drugs also induced an increase in p53-related proteins, such as p21, Bax, and IGF binding protein-3 (IGF-BP3), and caused a significant reduction of the Bcl-2 level. The latter effect was less evident in cells pretreated with IGF-I. CONCLUSIONS:Topoisomerase inhibitors induce apoptosis in Y79 cells. This event is accompanied by a decrease in the expression of Bcl-2, a death antagonist, and an increase in that of Bax, a death agonist. A probable consequence of these modifications is the activation of ICE-like activity with degradation of poly-(adenosine diphosphate [ADP] ribose)-polymerase. Insulin-like growth factor-I exerts an antiapoptotic action in Y79 cells, and this function is most likely reduced by the overexpression of IGF-BP3 that is induced by drug treatment

Case report: laser Nd:YAG e rieducazione funzionale nella sindrome del piriforme

La sindrome del piriforme \ue8 caratterizzata da una lombalgia con interessamento del gluteo e con possibile irradiazione all'arto inferiore; pu\uf2 essere definita come una patologia dovuta ad intrappolamento, compressione o irritazione del nervo sciatico a livello del muscolo piriforme con o senza deficit neurologici. In questo studio \ue8 stata valutata l'efficacia della sinergia terapeutica tra laser Neodimio:YAG e rieducazione funzionale nella riduzione del dolore e nel miglioramento dell'indipendenza funzionale in una paziente affetta da sindrome del piriforme

Ausencia de anticuerpos anti Trypanosoma cruzi en perros de barrios carenciados de la Ciudad de Buenos Aires, Argentina

El objetivo del trabajo fue detectar anticuerpos anti Trypanosoma cruzi en canes domiciliarios de dos barrios carenciados de la Ciudad de Buenos Aires, Argentina. Los barrios se eligieron en base a la presencia de personas y caninos procedentes de áreas endémicas, así como a las características de las viviendas, que por su precariedad favorecen la proliferación de insectos, además de albergar perros y aves de corral en su interior, en estrecha co–habitación con el hombre. Tales condiciones sugerían presunción de la existencia de serología positiva en los perros, originada tanto en su lugar de procedencia como en su hábitat actual. Entre marzo de 2005 y junio de 2006 fue recolectado suero sanguíneo de 424 caninos, preservándose en glicerina neutra tamponada, para luego ser examinado por inmunofluorescencia indirecta (IFI) y por enzimoinmunoensayo (ELISA). Se consideró positivo el suero que resultara reactivo para las dos pruebas efectuadas. En ningún suero estudiado se detectaron anticuerpos específicos anti T. cruzi, hecho que resulta coincidente con la falta de evidencias de infestación y transmisión por triatominos en la zona

Midterm Outcomes of the Nellix Endovascular Aneurysm Sealing System: A Dual-Center Experience

Purpose: To report midterm outcomes of the Nellix Endovascular Aneurysm Sealing (EVAS) System in the treatment of abdominal aortic aneurysm (AAA). Methods: Between September 2013 and July 2014, 64 AAA patients (mean age 76.6±6.8 years; 61 men) were treated with the EVAS system at 2 centers (only procedures performed at least 12 months prior to the analysis were included). Most patients were treated for a stable AAA, while 1 patient was treated for a ruptured aneurysm. Mean aneurysm diameter was 57.3±9.3 mm. The proximal neck measured a mean 21.5±3.3 mm in diameter and 27.0±12.1 mm long; the neck angle was 16.9°±19.3°. Eleven (17.2%) patients were treated outside the instructions for use (IFU). Results: Technical success was achieved in 63 (98.4%) of 64 patients; 1 type Ia endoleak was treated intraoperatively. One (1.6%) aneurysm-related death occurred at 4 months due to a secondary aortoenteric fistula. Overall, endoleaks occurred in 3 (4.7%) patients (2 type Ia, 1 type II). The estimated rates for 18-month overall survival, freedom from aneurysm-related death, and freedom from secondary interventions were 92.7%, 98.4%, and 95.0%, respectively. Patients treated outside the IFU had a significantly higher incidence of device-related complications (p=0.03). Conclusion: The use of the Nellix device in everyday clinical practice is safe and offers promising midterm results. The risk of secondary aortoenteric fistula requires further analysis. Longer follow-up is needed to assess the actual efficacy of the device, although the risk of migration with late endoleak seems low

WIN55,212-2-induced expression of Mir-29b1 favours the suppression of osteosarcoma cell migration in a SPARC-independent manner

WIN55,212-2 (WIN) is a synthetic agonist of cannabinoid receptors that displays promising antitumour properties. The aim of this study is to demonstrate that WIN is able to block the migratory ability of osteosarcoma cells and characterize the mechanisms involved. Using wound healing assay and zymography, we showed that WIN affects cell migration and reduces the activity of the metalloproteases MMP2 and MMP9. This effect seemed to be independent of secreted protein acidic and rich in cysteine (SPARC), a matricellular protein involved in tissue remodeling and extracellular matrix deposition. SPARC release was indeed prevented by WIN, and SPARC silencing by RNA interference did not influence the effect of the cannabinoid on cell migration. WIN also increased the release of extracellular vesicles and dramatically upregulated miR-29b1, a key miRNA that modulates cell proliferation and migration. Interestingly, reduced cell migration was observed in stably miR-29b1-transfected cells, similarly to WIN-treated cells. Finally, we show the absence of SPARC in the extracellular vesicles released by osteosarcoma cells and no changes in SPARC level in miR-29b1 overexpressing cells. Overall, these findings suggest that WIN markedly affects cell migration, dependently on miR-29b1 and independently of SPARC, and can thus be considered as a potential innovative therapeutic agent in the treatment of osteosarcoma